戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 mic alterations and are thus key targets for cancer chemoprevention.
2 combining lovastatin with sulindac for colon cancer chemoprevention.
3 ations for understanding and improving colon cancer chemoprevention.
4 t retinoids are potentially useful agent for cancer chemoprevention.
5 sion and improving response to iloprost lung cancer chemoprevention.
6 ing FENR, offering a new approach for breast cancer chemoprevention.
7 he effectiveness of antioxidants in prostate cancer chemoprevention.
8 d xenobiotic electrophiles is a strategy for cancer chemoprevention.
9 on of curcumin as a novel approach to breast cancer chemoprevention.
10 r to take tamoxifen or raloxifene for breast cancer chemoprevention.
11 mendations on the use of 5-ARIs for prostate cancer chemoprevention.
12 a-reductase inhibitors (5-ARIs) for prostate cancer chemoprevention.
13 activating agents are in clinical trials for cancer chemoprevention.
14  of nanotechnology to improve the outcome of cancer chemoprevention.
15 vitamin E plays in photo-protection and skin cancer chemoprevention.
16 clins as molecular pharmacologic targets for cancer chemoprevention.
17 ues suggest that antioxidants may be used in cancer chemoprevention.
18  as a potential novel drug target for breast cancer chemoprevention.
19 as a candidate-pharmacologic target for lung cancer chemoprevention.
20  prevent colon cancer are recent examples of cancer chemoprevention.
21 hat fruit polyphenols have the potential for cancer chemoprevention.
22 uld be placed on smoking prevention and lung cancer chemoprevention.
23 h as catechin, may play an important role in cancer chemoprevention.
24 h within the increasingly important field of cancer chemoprevention.
25 d may define effective targets for achieving cancer chemoprevention.
26 hylated selenium metabolite is important for cancer chemoprevention.
27 2 gene expression and the roles of NSAIDs in cancer chemoprevention.
28 te their clinical potential in head and neck cancer chemoprevention.
29 on and proliferation is an important goal in cancer chemoprevention.
30 iindolylmethane (DIM) has been known to have cancer chemoprevention activity.
31 ZD9) is critical to the activity of the lung cancer chemoprevention agent and prostacyclin analogue,
32 ional Cancer Institute's Phase I/II prostate cancer chemoprevention agent development program.
33                The potential for utilizing a cancer chemoprevention agent that may simultaneously red
34 could help explain its lack of efficacy as a cancer chemoprevention agent.
35 aded ethosomes for minimally invasive breast cancer chemoprevention, aiming to enhance local drug dis
36 dely reported to display strong efficacy for cancer chemoprevention, although their mechanism of acti
37   Since RXRs represent important targets for cancer chemoprevention, an ultrafiltration mass spectrom
38 l usefulness of this new mouse model in lung cancer chemoprevention and chemotherapy was examined.
39  is an approved drug in the clinic for colon cancer chemoprevention and has been tested for its chemo
40 ed as potential selenium delivery agents for cancer chemoprevention and other clinical uses.
41 , PKCbetaII is an important target for colon cancer chemoprevention and the PKCbeta-selective inhibit
42 pletion may be an important novel target for cancer chemoprevention and therapy by natural and synthe
43    Retinoids have shown clinical efficacy in cancer chemoprevention and therapy presumably by modulat
44 de (4HPR), a synthetic retinoid effective in cancer chemoprevention and therapy, is thought to act vi
45           Retinoids are promising agents for cancer chemoprevention and therapy.
46 icroparticles is a promising new approach to cancer chemoprevention and therapy.
47 y of this element is a promising strategy of cancer chemoprevention and therapy.
48 ical studies and in a few clinical trials of cancer chemoprevention and therapy.
49        Vitamin D is a well-studied agent for cancer chemoprevention and treatment.
50 er tumors, suggesting a new target for liver cancer chemoprevention and/or chemotherapy.
51 epresent a dramatic impact on the history of cancer chemoprevention, and if not successful the potent
52  is the only drug approved for use in breast cancer chemoprevention, and it remains the treatment of
53 nale for using selective COX-2 inhibitors in cancer chemoprevention, and outline new avenues of resea
54 s in regulating cell death in the context of cancer chemoprevention, and present a paradigm for devel
55                        The key principles of cancer chemoprevention are discussed and areas for impro
56 on chemical carcinogenesis as an approach to cancer chemoprevention, as well as studies on the inhibi
57 y moderately effective in JMML assays and in cancer chemoprevention assays.
58  potent rexinoid that is highly effective in cancer chemoprevention but elevates serum triglycerides.
59                                              Cancer chemoprevention by induction of phase 2 proteins
60 ngiogenesis may be an important mechanism in cancer chemoprevention by PEITC.
61 otentially selective approach for colorectal cancer chemoprevention by targeting APC-deficient cells
62 Epidemiological data and in vitro studies on cancer chemoprevention by tea polyphenols have gained at
63 rom Se-methylselenocysteine is a key step in cancer chemoprevention by this agent.
64                                         Lung cancer chemoprevention continued to make progress in 199
65  for novel agent(s) for the armamentarium of cancer chemoprevention continues.
66 ovided information about hypothetical breast cancer chemoprevention decisions (mean uptake rate, 24.7
67 aB) is believed to play an important role in cancer chemoprevention due to its involvement in tumor c
68                    Despite great interest in cancer chemoprevention, effective agents are few.
69  class of naturally occurring compounds with cancer chemoprevention effects that have become clinical
70                                              Cancer chemoprevention has many challenges to face but t
71 r, few molecular targets for effective colon cancer chemoprevention have been characterized and valid
72 1 antibodies may be useful for treatment and cancer chemoprevention in IBD.
73  strategies to modulate polyamine levels for cancer chemoprevention in individuals at high risk of de
74 Whether oral nicotinamide is useful for skin-cancer chemoprevention in organ-transplant recipients is
75 as management of biliary tract dysplasia and cancer chemoprevention in PSC.
76   We also appraise the four trials of breast-cancer chemoprevention, including the trial that has led
77  Aromatase inhibitors are established breast cancer chemoprevention interventions.
78                                     Prostate cancer chemoprevention is an alternative and potential s
79                                  Research on cancer chemoprevention is an important approach for decr
80              To maximize the benefit of lung cancer chemoprevention, it is important to identify indi
81                   In addition, the potential cancer chemoprevention of the secondary metabolites (phe
82 ures of ACF that may provide new targets for cancer chemoprevention or lead to the development of new
83 rs of these isoforms may be useful in breast cancer chemoprevention or therapy.
84 ents will hopefully streamline head and neck cancer chemoprevention research.
85 esis have led to novel molecular targets for cancer chemoprevention research.
86  impact would again be a landmark finding in cancer chemoprevention; so the time is more than ripe fo
87 helial cancers and may have implications for cancer chemoprevention strategies.
88                                           In cancer chemoprevention studies, the identification of be
89 wever, vit C has proved to be ineffective in cancer chemoprevention studies.
90   On the basis of these results, a full-term cancer chemoprevention study was conducted with DMBA-tre
91                Soy isoflavones are potential cancer chemoprevention treatments.
92 ffects of long-term retinol intake in a skin cancer chemoprevention trial in a large population at mo
93 gn and rationale of the dutasteride prostate cancer chemoprevention trial known as the REDUCE trial (
94 terventions to be utilized in the next major cancer chemoprevention trial.
95 upplements may be utilized in the next major cancer chemoprevention trial.
96 the use of a heart healthy agent in the nest cancer chemoprevention trial.
97 ouragement for the use of tazarotene in skin cancer chemoprevention trials in humans.
98 been definitive, randomized, controlled lung-cancer chemoprevention trials in the three chemopreventi
99 e of death in the largest dietary supplement cancer chemoprevention trials.
100 deration for evaluation in clinical prostate cancer chemoprevention trials.
101 the number one cause of death in the largest cancer chemoprevention trials; CVD is the number one or
102                                       Breast cancer chemoprevention uptake rates are low and variatio
103                                              Cancer chemoprevention uses natural, synthetic, or biolo
104 t PKCbetaII is an effective target for colon cancer chemoprevention using enzastaurin (LY317615), a P
105 nancy, they have started to be implicated in cancer chemoprevention, via the targeting of reversible
106 roach for detecting potential biomarkers for cancer chemoprevention was evaluated in rat mammary tumo
107 e usefulness of this new mouse model in lung cancer chemoprevention was examined.
108 hat addressed patient decisions about breast cancer chemoprevention, were published in 1995 or later,
109 nt given that any use of aspirin for ovarian cancer chemoprevention will likely need to focus on spec
110                           The future of lung cancer chemoprevention will rely heavily on molecular st
111 1 inhibition may be a promising strategy for cancer chemoprevention with lack of the adverse cardiova
112 identify women who might benefit from breast-cancer chemoprevention with tamoxifen or be suitable for
113 how the feasibility of targeting mPGES-1 for cancer chemoprevention with the potential for improved t
114                         A novel approach for cancer chemoprevention would involve LOX modulators, i.e

 
Page Top